PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15092795

[Not Available].

A Venant·G Cumont
View original source ↗Export metadata ↓

Abstract

An OECD study of contaminants in animals sampled from the wild is reviewed briefly. Results are presented of analysis of residues of organochlorines of agricultural origin, and of PCBs, in samples of fish taken from the French zone of Lac Léman at Thonon-les-Bains. Trends in organochlorine contamination in muscle of Perca fluviatilis and Rutilus rutilus are presented, for the years 1973 to 1981, and show low levels of the chemicals. All values found are lower than the maximum acceptable residue limits set by several countries for fish for human consumption; many were below the limit of detection of the analytical methods. Results are consistent with published studies by other authors.

Explore related subjects

English AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Venant, G Cumont. 1987. [Not Available].. https://doi.org/10.1016/0269-7491(87)90153-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Increased risk of infection in patients with diabetes mellitus type 1 or 2].

OBJECTIVE: To determine the risk of common infections in patients with diabetes mellitus type 1 (DM1) or type 2 (DM2). DESIGN: Prospective controlled study. METHODS: In a 12-month prospective cohort study as part of the Second Dutch National Survey of General Practice, 705 adult DM1 and 6,712 DM2 patients were compared with 18,911 control patients who had hypertension without diabetes. Outcome measures were medically-attended episodes of infections of the respiratory tract, urinary tract, skin and mucous membranes. Multivariate and multinomial logistic regression analysis was applied to determine independent risks of infections and their recurrence in patients with diabetes compared to controls. RESULTS: Upper respiratory-tract infections were as common in diabetes patients as in controls. Diabetes patients had a higher risk of lower respiratory-tract infections (DM2: odds ratio (OR): 1.30; 95% CI: 1.11-1.52), urinary-tract infections (DM1: OR: 1.56; 95% CI: 1.13-2.15; DM2: OR: 1.21; 95% CI: 1.07-1.38), bacterial skin or mucous-membrane infections (DM1: OR: 1.48; 95% CI: 1.01-2.15; DM2: OR: 1.32; 95% CI: 1.13-1.55) and mycotic skin or mucous-membrane infections (DM2: OR: 1.41; 95% CI: 1.24-1.61). The risk of recurrence of these common infections was seen to be increased. CONCLUSIONS: Patients with type-1 and type-2 diabetes are at increased risk of lower respiratory-tract infections, urinary-tract infections and skin or mucous-membrane infections.

English Abstract↗
PubMed2006

[Hyoidothyroidopexy as a surgical treatment for obstructive sleep apnoea syndrome].

OBJECTIVE: To evaluate the results ofhyoidothyroidopexy (HTP) in patients with obstructive sleep apnoea syndrome (OSAS). DESIGN: Prospective, descriptive. METHOD: Data were collected on patients with moderate to severe OSAS that underwent HTP between 1 March 2000 and 30 June 2004 in the St. Lucas Andreas Hospital in Amsterdam. All patients had an obstruction at the level ofthe base ofthe tongue and, to a lesser degree, the palate and either refused the use of continuous positive airway pressure (CPAP) or were unable to tolerate this treatment. The following scores were calculated preoperatively and 3 months after the operation: the apnoeahypopnoea index (AHI), apnoea index, Epworth sleepiness scale, desaturation index and visual analogue scores for hypersomnolence, snoring and pain sensation. RESULTS: During the period under investigation, 31 patients underwent HTP: 29 men and 2 women. Of these, 14 had never been operated before at the oral or hypopharyngeal level (average age: 47 years; average BMI: 26.3) and 17 had undergone unsuccessful uvulopalatopharyngoplasty (average age: 46.3 years; average BMI: 27.7). Of the 31 patients, 16 (52%) had a significant decrease in the AHI, especially those in the primary HTP-group (10/14 or 71% vs. 6/17 or 35% in the secondary group, p > 0.05). The average AHI decreased from 32.9 to 11.9 (p = 0.006) in the primary group and from 31.5 to 26.2 (p = 0.06) in the secondary group. Most of the secondary outcome measures improved statistically significantly in both groups. In one patient, tracheotomy was performed due to postoperative bleeding that threatened to obstruct the respiratory tract. CONCLUSION The short-term results of HTP as the primary treatment in patients with moderate to severe OSAS could be characterised as favourable.

English Abstract↗
PubMed2005

[Critical appraisal: combined T3 and T4 replacement therapy is not better than replacement with T4 alone].

Conflicting results have recently been published about the benefits of combined thyroxine (T4) and triiodothyronine (T3) in treating hypothyroid patients. However these studies may have been underpowered to detect differences in psychological well-being specifically related to thyroxine replacement. We conducted a large, double-blind, randomized controlled trial of partial substitution of 50 microg of T4 by 10 microg of T3 (T3) vs placebo (T4 alone - 50 microg of T4 replaced) in 697 hypothyroid patients. Thyroid function showed a rise in the TSH (132%), a fall in Free T4 (35%, P <0.001) and unchanged basal Free T3 levels (P=0.92). At 3 months there was a large (39%) < > improvement in < > defined by the General Health Questionnaire 12 score (GHQ 12) in the control group compared with baseline and this was sustained at 12 months. Differences vs the intervention (T3) group were more modest with improvements in GHQ caseness (OR - 0.61; 95% CI: 0.42, 0.90; P=0.01) and HADS anxiety scores at 3 months (P <0.03) but not GHQ Likert scores, HADS depression, thyroid symptoms or visual analog scales of mood and the initial differences were lost at 12 months. These results may be consistent with a subgroup of patients showing transient improvement following partial substitution with T3 but do not provide conclusive evidence of specific benefit from partial substitution of T4 by T3 in patients on thyroxine replacement. They also emphasize the large and sustained < > that can follow changes in thyroid hormone administration.

English Abstract↗